Jonathan H. Lin

Conjunctival histopathological changes associated with netarsudil 0.02.

Conjunctiva treated with netarsudil may be more likely to demonstrate inflammation compared to those treated with other combinations of glaucoma medications. These findings may have surgical implications and additional studies correlating clinical outcomes are required.